Northland Capital Markets Starts Tilray (TLRY) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
Roth Capital Starts Tilray (TLRY) at Buy
August 14, 2018 5:31 AM EDTRoth Capital analyst Charles Finnie initiates coverage on Tilray (NASDAQ: TLRY) with a Buy rating and a price target of $35.00.
The analyst favors the company's position as a global cannabis leader
For an analyst ratings summary and ratings history on Tilray... More
Cowen Starts Tilray (TLRY) at Outperform
August 13, 2018 5:37 AM EDTCowen analyst Vivien Azer initiates coverage on Tilray (NASDAQ: TLRY) with a Outperform rating and a price target of $34.00.
Azer comments "As the adult use cannabis market gets ready to kick-off in Canada on October 17, TLRY is set to become an early category leader with... More
